uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

$864.2M

Market Cap • 12/26/2024

2012

(12 years)
Founded

2014

(10 years ago)
IPO

NASDAQ

Listing Exchange
Flag of NL

Amsterdam

Headquarters • NH